GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly becoming a significant focus in medical investigation, largely due to its notable impact on controlling conditions such as adult-onset diabetes and obesity. Ongoing studies have revealed that more than glucose control, GLP-1 agonists offer benefits for heart health and perhaps b